Religare puts US$16.3M into Care Health Insurance rights issue
What's the deal? Religare EnterprisesDealroom has a profile for this one. Try Dealroom → Limited (REL) has subscribed to 7,480,324 equity shares in the rights issue of its subsidiary, Care Health InsuranceDealroom has a profile for this one. Try Dealroom → Limited (CHIL). The shares were issued at a face value of US$0.14 each plus a premium of US$2.04, taking the total to US$16.3M. The allotment was completed on June 30, 2026, and the acquisition finalised on July 8, 2026.
Why now? The proceeds are earmarked to fund CHIL's expansion plans and meet its statutory solvency requirements. Religare, registered with the Reserve Bank of India as a Core Investment Company, said the move fits its core business of investing in and lending to group companies.
What's the endgame? CHIL, incorporated on April 2, 2007, operates in health insurance. As of March 31, 2026, it ran 277 branches, employed over 13,000 people, and served more than three million policyholders.
Its turnover has climbed steadily: US$953.6M in FY2023-24, US$1.16B in FY2024-25, and US$1.41B in FY2025-26.
What could go wrong? As a material unlisted subsidiary, CHIL's rights issue makes the investment a related party transaction. Religare said it was conducted at arm's length, as the price was uniform for all shareholders.
The signal: The capital injection underscores Religare's commitment to scaling its insurance arm as CHIL crosses the US$1.36B turnover mark. Religare shares closed at US$3.61 on the day, down 2.26%.
Read more: Investoomarket
Image credit: MattHurst
